CEO to discuss company’s AAV gene therapy manufacturing and company achievements
over the past 12 months
COLUMBUS, OHIO, October 11, 2021 – Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that Timothy J. Miller, Ph.D., CEO, President and Co-Founder, will discuss Forge’s robust AAV manufacturing solutions, proprietary technology advancements, and clinical development during a company presentation at Cell & Gene Meeting on the Mesa on October 12 at 5:00 p.m. PT.
Dr. Miller will also join a panel of gene therapy experts for a discussion on “Dosing & Redosing in Gene Therapy,” October 14 at 11:00 a.m. PT.
The conference will take place October 12-14, 2021, at the Park Hyatt Aviara, in Carlsbad, California. To learn more about the event and registration, please visit: https://meetingonthemesa.com.
Forge will be taking meetings during Meeting on the Mesa. Please contact John Maslowski, Chief Commercial Officer, at CD@forgebiologics.com if you are interested in connecting and learning more about how Forge’s manufacturing solutions can support your gene therapy program.
About Forge Biologics
Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit www.forgebiologics.com
Senior Manager, Marketing and Communications
Families and Clinician Inquiries
Dr. Maria Escolar
Chief Medical Officer
Vice President, Head of Business Development
Chief Commercial Officer
Christina Perry, MSA, CPA
Vice President, Finance and Investor Relations